Beta Thalassemia News and Research

RSS
Beta-thalassemia (ß-thalassemia) is a form of thalassemia due to mutations in the HBB gene on chromosome 11 , inherited in an autosomal recessive fashion.
New gene transfer technique can treat beta-thalassemia, sickle cell anemia

New gene transfer technique can treat beta-thalassemia, sickle cell anemia

New gene editing technique can heal sickle cell patients with their own cells

New gene editing technique can heal sickle cell patients with their own cells

FDA licenses NYBC's HEMACORD stem cell product

FDA licenses NYBC's HEMACORD stem cell product

Acceleron commences ACE-536 Phase 1 clinical trial in anemia

Acceleron commences ACE-536 Phase 1 clinical trial in anemia

EGT transfers clinical grade lentiviral vector to MSKCC

EGT transfers clinical grade lentiviral vector to MSKCC

genOway acquires worldwide exclusive license for RMCE technology from bluebird bio for genetically modified rodents

genOway acquires worldwide exclusive license for RMCE technology from bluebird bio for genetically modified rodents

bluebird bio announces receipt of additional $30 million in financing

bluebird bio announces receipt of additional $30 million in financing

Metallic copper surfaces kill bacteria on contact

Metallic copper surfaces kill bacteria on contact

Researchers report gene therapy strategy that improves Beta Thalassemia in mice model

Researchers report gene therapy strategy that improves Beta Thalassemia in mice model

Hepcidin hormone may be potential therapeutic tool for anemic blood disorders

Hepcidin hormone may be potential therapeutic tool for anemic blood disorders

bluebird bio publishes LentiGlobin gene therapy clinical trial data results

bluebird bio publishes LentiGlobin gene therapy clinical trial data results

HemaQuest closes additional $4M to Series B financing

HemaQuest closes additional $4M to Series B financing

NHLBI funds nine research grants to determine safety and efficacy of red blood cell transfusions

NHLBI funds nine research grants to determine safety and efficacy of red blood cell transfusions

HemaQuest Pharmaceuticals closes $12M Series B financing

HemaQuest Pharmaceuticals closes $12M Series B financing

Innovative drug design wins medical research prize

Innovative drug design wins medical research prize

Pathway Genomics' personal Genetic Health Report now available

Pathway Genomics' personal Genetic Health Report now available

Genetix Pharmaceuticals announces completion of $35M Series B financing

Genetix Pharmaceuticals announces completion of $35M Series B financing

Promising results in mice could prevent fatal iron buildup in humans

Promising results in mice could prevent fatal iron buildup in humans

Simple, five minute saliva test to determine baby's risk for more than 100 life-threatening genetic diseases

Simple, five minute saliva test to determine baby's risk for more than 100 life-threatening genetic diseases

Hemaquest Pharmaceuticals' HQK-1001 holds promise for sickle cell disease and beta thalassemia

Hemaquest Pharmaceuticals' HQK-1001 holds promise for sickle cell disease and beta thalassemia